Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States

Journal of Occupational and Environmental Medicine

Volumn 50, Issue 9, 2008, Pages 998-1005

  White, Alan G ^a   Birnbaum, Howard G ^a   Janagap, Carmela ^b   Buteau, Sharon ^a   Schein, Jeff ^b  

^a ANALYSIS GROUP   (United States)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; COCODAMOL; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROTON PUMP INHIBITOR; TRAMADOL; CYCLOOXYGENASE 2; NARCOTIC ANALGESIC AGENT;

ABSENTEEISM; ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; DATA BASE; DRUG COST; DRUG UTILIZATION; EMPLOYER; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; OSTEOARTHRITIS; PAIN; PRESCRIPTION; PREVALENCE; UNITED STATES; COST; ECONOMICS; INSURANCE; MIDDLE AGED; PATHOPHYSIOLOGY;

ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COST OF ILLNESS; COSTS AND COST ANALYSIS; CYCLOOXYGENASE 2; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE COVERAGE; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN; TRAMADOL; UNITED STATES;

EID: 62649112600     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181715111     Document Type: Article

References (17)

1. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet. 1999;354:1248-1252.
2. Singh G, Miller JD, Lee FH, Pettitt D, Russell MW. Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Am J Manag Care. 2002;8:S383-S391.
3. Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84:351-358.
4. Breedveld FC. Osteoarthritis - the impact of a serious disease. Rheumatology (Oxford). 2004;43 Suppl 1:i4-i8.
5. Groessl EJ, Kaplan RM, Cronan TA. Quality of well-being in older people with osteoarthritis. Arthritis Rheum. 2003;49:23-28.
6. Marks R, Allegrante JP. Comorbid disease profiles of adults with end-stage hip osteoarthritis. Med Sci Monit. 2002;8: CR305-CR309.
7. Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol. 1999;26:2475-2479.
8. Lapsley HM, March LM, Tribe KL, Cross MJ, Brooks PM. Living with osteoarthritis: patient expenditures, health status, and social impact. Arthritis Rheum. 2001;45:301-306.
9. White AG, Birnbaum HG, Mareva MN, Henckler AE, Grossman P, Mallett DA. Economic burden of illness for employees with painful conditions. J Occup Environ Med. 2005;47:884-892.
10. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290: 2443-2454.
11. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43:1905-1915.
12. DeAngelo NA, Gordin V. Treatment of patients with arthritis-related pain. J Am Osteopath Assoc. 2004;104:S2-S5.
13. Blumstein H, Gorevic PD. Rheumatologic illnesses: treatment strategies for older adults. Geriatrics. 2005;60:28-35.
14. Cote LG. Management of osteoarthritis. J Am Acad Nurse Pract. 2001;13:495-501.
15. Available at: http://www.who.int/ classifications/icf/en
16. Weinstein SM, Laux LF, Thornby JI, et al. Physicians' attitudes toward pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain Initiative. South Med J. 2000;93:479-487.
17. Pain: Current Understanding of Assessment, Management, and Treatments. National Pharmaceutical Council, Inc. and Joint Commission on Accreditation of Healthcare Organizations. 2001. Availableat: http://www.npcnow.org/resources/ PDFs/painmonograph.pdf.